Early July 2018 the CEO of Abomics, PhD Jari Forsström, had a pleasure to meet a prestige delegation from the Southern Medical University, China. The delegation visited Finland with the agenda of getting familiar with the local healthcare system and to learn more about the companies working innovatively in the frontier of contemporary health technology.
Southern Medical University, SMU, has a very respectful history starting from 1951 and it is highly respected academic facility that offers advanced level education. The SMU is one of the eight prestigious universities authorized by the Chinese Ministry of Education to run the pilot 8-year medical education program. Some of the most respected academic university hospitals in China are included within the SMU.
The delegation had requested a meeting with Abomics due to their in-depth interest in opportunities regarding the utilization of genomic data. The respectful delegation expressed pharmacogenetics as their special interest. For this purpose, Abomics was a perfect partner.
The meeting was very successful and lead into further discussions. The SMU wishes to continue the conversation that will potentially lead into further contracts between the two, Abomics and the Southern Medical University. Abomics is looking forward to provide state-of-the-art pharmacogenetic interpretations and will do their utmost best to ensure this co-operation will get a smooth start.